# Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer

> **NCT00849121** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 17 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** pTVG-HP with rhGM-CSF
- **BIOLOGICAL:** pTVG-HP with rhGM-CSF

## Key facts

- **NCT ID:** NCT00849121
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-16
- **Primary completion:** 2014-02-17
- **Final completion:** 2014-02-17
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849121, "Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00849121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*